|
C20ORF7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.459000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.410390E-01 |
| Normal-vs-Stage2 |
4.091800E-01 |
| Normal-vs-Stage3 |
4.406200E-01 |
| Normal-vs-Stage4 |
5.826000E-01 |
| Stage1-vs-Stage2 |
9.489200E-01 |
| Stage1-vs-Stage3 |
9.297400E-01 |
| Stage1-vs-Stage4 |
3.046400E-01 |
| Stage2-vs-Stage3 |
9.904200E-01 |
| Stage2-vs-Stage4 |
3.311000E-01 |
| Stage3-vs-Stage4 |
4.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.876040E-01 |
| Normal-vs-AfricanAmerican |
2.294800E-01 |
| Normal-vs-Asian |
9.514200E-01 |
| Caucasian-vs-AfricanAmerican |
8.133800E-01 |
| Caucasian-vs-Asian |
7.045800E-01 |
| AfricanAmerican-vs-Asian |
6.282600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.510800E-01 |
| Normal-vs-Female |
4.915200E-01 |
| Male-vs-Female |
9.037600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.390800E-01 |
| Normal-vs-Extreme_Weight |
2.102600E-01 |
| Normal-vs-Obese |
4.109600E-01 |
| Normal-vs-Extreme_Obese |
2.097800E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.095600E-01 |
| Normal_Weight-vs-Obese |
7.015600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.592200E-01 |
| Extreme_Weight-vs-Obese |
7.855400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.416200E-01 |
| Obese-vs-Extreme_Obese |
2.097800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.736800E-01 |
| Normal-vs-Age(41-60Yrs) |
2.227800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.707580E-01 |
| Normal-vs-Age(81-100Yrs) |
5.931900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.806400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.461800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.933800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.848400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.012140E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.695300E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.155600E-02 |
| Normal-VS-Type2 PRCC |
6.117200E-01 |
| Normal-VS-KIRP CIMP |
1.82390000003085E-06 |
| Normal-VS-Unclassified PRCC |
2.460600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.076400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.69518999999507E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
7.071600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.18360000000728E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
3.914400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.006940E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.133400E-01 |
| Normal-vs-N1 |
8.688800E-01 |
| Normal-vs-N2 |
1.462360E-03 |
| N0-vs-N1 |
9.804400E-01 |
| N0-vs-N2 |
4.499900E-02 |
| N1-vs-N2 |
1.885970E-01 |
|
|
